Trial Profile
A Retrospective Study Assessing the Effect of Topical Tacrolimus Alone or in Combination with Steroids for the Treatment of Shield Ulcers and Corneal Epitheliopathy in Patients with Refractory Allergic Ocular Diseases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jul 2017
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Steroids; Steroids
- Indications Allergic conjunctivitis; Corneal disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Senju Pharmaceutical
- 25 Jul 2017 New trial record